The present invention provides an integrase inhibitor. The inventors have have found the following compound of formula (I) possessing an integrase inhibitory activity.
1
(wherein, R
C
and R
D
taken together with the neighboring carbon atoms form a ring which may be a condensed ring, Y is hydroxy, mercapto or amino; Z is O, S or NH; R
A
is a group shown by
2
(wherein, C ring is N-containing aromatic heterocycle) or the like)
The present invention provides an integrase inhibitor. The inventors have have found the following compound of formula (I) possessing an integrase inhibitory activity.
(wherein, RC and RD taken together with the neighboring carbon atoms form a ring which may be a condensed ring, Y is hydroxy, mercapto or amino; Z is O, S or NH ;
RA is a group shown by
(wherein, C ring is N-containing aromatic heterocycle) or the like)
本发明提供了一种整合酶抑制剂。本发明者发现了以下具有整合酶抑制活性的式 (I) 化合物。
(其中,RC 和 RD 与邻近的碳原子共同形成一个环,该环可以是缩合环;Y 是羟基、巯基或氨基;Z 是 O、S 或 NH;
RA 是以下所示的基团
(其中,C 环为含 N 的芳香杂环)或类似物)。
3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as advanced inhibitors of HIV integrase
The two-metal binding model we previously reported as an inhibition mechanism of HIV integrase (HIV IN) produced a new direction in modification of 2-hydroxy-3-heteroaryl acrylic acid inhibitors (HHAAs). Here we present a novel series of HIV IN inhibitors having a 3-hydroxy-1,5-dihydro-pyrrol-2-one moiety (HDPO) as an advanced analog of HHAAs. This cyclic modification of the chelating region of HHAA produces a favorable configuration to coordinate two-metal ions in HIV IN, which consequently gave improvements in not Only enzymatic assay but also antiviral cell based assay in many cases. (c) 2007 Elsevier Ltd. All rights reserved.